XML 20 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE COMMON SHARES AND SHAREHOLDERS'' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Convertible Common Shares
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings (Accumulated Deficit)
Balance at Dec. 31, 2019 $ 1,480,158   $ 20,801 $ 1,720,129 $ (18,854) $ (241,918)
Balance, Shares at Dec. 31, 2019     166,410      
Net issuance of common stock under stock-based plans 3,163   $ 144 3,019    
Net issuance of common stock under stock-based plans (in shares)     1,150      
Stock-based compensation expense 33,683     33,683    
Repurchase of common stock $ (88,465)   $ (190)     (88,275)
Repurchase of common stock (in shares) 1,500   (1,517)      
Cash dividends $ (49,912)         (49,912)
Net income 587,815         587,815
Other comprehensive income (loss) 27,102       27,102  
Balance at Sep. 27, 2020 1,993,544   $ 20,755 1,756,831 8,248 207,710
Balance, Shares at Sep. 27, 2020     166,043      
Balance at Jun. 28, 2020 1,744,551   $ 20,725 1,730,716 (8,500) 1,610
Balance, Shares at Jun. 28, 2020     165,806      
Net issuance of common stock under stock-based plans 13,545   $ 30 13,515    
Net issuance of common stock under stock-based plans (in shares)     237      
Stock-based compensation expense 12,600     12,600    
Cash dividends (16,618)         (16,618)
Net income 222,718         222,718
Other comprehensive income (loss) 16,748       16,748  
Balance at Sep. 27, 2020 1,993,544   $ 20,755 1,756,831 8,248 207,710
Balance, Shares at Sep. 27, 2020     166,043      
Balance at Dec. 31, 2020 2,207,018   $ 20,765 1,765,323 33,516 387,414
Balance, Shares at Dec. 31, 2020   3,787 166,123      
Net issuance of common stock under stock-based plans 64   $ 112 (48)    
Net issuance of common stock under stock-based plans (in shares)     893      
Stock-based compensation expense 35,915     35,915    
Repurchase of common stock $ (416,180)   $ (411)     (415,769)
Repurchase of common stock (in shares) 3,300   (3,288)      
Cash dividends $ (49,757)         (49,757)
Settlements of convertible notes 841,202   $ 897 840,305    
Settlement of convertible debt (in shares)     7,178      
Exercise of convertible notes hedge call options (842,925)   $ (897) (842,028)    
Exercise of convertible notes hedge call options (in shares)     (7,178)      
Convertible common shares 906     906    
Convertible common shares (in shares)   (906)        
Net income 790,549         790,549
Other comprehensive income (loss) (29,299)       (29,299)  
Balance at Oct. 03, 2021 2,537,493   $ 20,466 1,800,373 4,217 712,437
Balance, Shares at Oct. 03, 2021   2,881 163,728      
Balance at Jul. 04, 2021 2,493,256   $ 20,680 1,772,302 15,322 684,952
Balance, Shares at Jul. 04, 2021   21,386 165,444      
Net issuance of common stock under stock-based plans (258)   $ 1 (259)    
Net issuance of common stock under stock-based plans (in shares)     8      
Stock-based compensation expense 10,042     10,042    
Repurchase of common stock (212,996)   $ (215)     (212,781)
Repurchase of common stock (in shares)     (1,724)      
Cash dividends (16,452)         (16,452)
Settlements of convertible notes 637,497   $ 699 636,798    
Settlement of convertible debt (in shares)     5,589      
Exercise of convertible notes hedge call options (637,714)   $ (699) (637,015)    
Exercise of convertible notes hedge call options (in shares)     (5,589)      
Convertible common shares 18,505     18,505    
Convertible common shares (in shares)   (18,505)        
Net income 256,718         256,718
Other comprehensive income (loss) (11,105)       (11,105)  
Balance at Oct. 03, 2021 $ 2,537,493   $ 20,466 $ 1,800,373 $ 4,217 $ 712,437
Balance, Shares at Oct. 03, 2021   2,881 163,728